255 related articles for article (PubMed ID: 6084613)
1. Characterization of rabies virus strains used for vaccine production by means of monoclonal antibodies.
Sureau P; Rollin P; Lafon M
Dev Biol Stand; 1984; 57():227-31. PubMed ID: 6084613
[TBL] [Abstract][Full Text] [Related]
2. [Antigenic spectrum of wild strains and vaccinal strains of rabies virus in Senegal defined by antinucleocapsid monoclonal antibodies].
Digoutte JP
Arch Inst Pasteur Tunis; 1982 Mar; 59(1):99-103. PubMed ID: 7181573
[No Abstract] [Full Text] [Related]
3. Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies.
Wiktor TJ; Macfarlan RI; Foggin CM; Koprowski H
Dev Biol Stand; 1984; 57():199-211. PubMed ID: 6526138
[TBL] [Abstract][Full Text] [Related]
4. Common and different antigenic properties of the rabies virus glycoprotein of strains SAD-Vnukovo and Pitman-Moore.
Máciková I; Dedek L; Vrzal V; Kontseková E; Kontsek P; Ciampor F; Novák M
Acta Virol; 1992 Dec; 36(6):541-50. PubMed ID: 1284868
[TBL] [Abstract][Full Text] [Related]
5. Binding properties of monoclonal antibodies to rabies virus.
Cusi MG; Valensin PE; Tollis M; Bracci L; Petreni S; Soldani P
Microbiologica; 1991 Jul; 14(3):205-11. PubMed ID: 1921740
[TBL] [Abstract][Full Text] [Related]
6. Use of monoclonal antibodies to confirm vaccine-induced rabies in ten dogs, two cats, and one fox.
Whetstone CA; Bunn TO; Emmons RW; Wiktor TJ
J Am Vet Med Assoc; 1984 Aug; 185(3):285-8. PubMed ID: 6540768
[TBL] [Abstract][Full Text] [Related]
7. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK
Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies as a tool for rabies epidemiological studies.
Rollin PE; Sureau P
Dev Biol Stand; 1984; 57():193-7. PubMed ID: 6084611
[TBL] [Abstract][Full Text] [Related]
9. Peptide mimotopes of rabies virus glycoprotein with immunogenic activity.
Houimel M; Dellagi K
Vaccine; 2009 Jul; 27(34):4648-55. PubMed ID: 19520204
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody characterization of rabies virus isolates from Russia, Finland and Estonia.
Metlin AE; Cox J; Rybakov SS; Huovilainen A; Grouzdev KN; Neuvonen E
J Vet Med B Infect Dis Vet Public Health; 2004 Mar; 51(2):94-6. PubMed ID: 15030608
[TBL] [Abstract][Full Text] [Related]
11. [Antigenic determination of human anti-rabies vaccine against viral street strains common in the wild animal population in Poland].
Seroka D
Med Dosw Mikrobiol; 1994; 46(4):331-47. PubMed ID: 7541494
[TBL] [Abstract][Full Text] [Related]
12. [Production of monoclonal antibodies against a wild strain of rabies virus].
Akacem O; Benmansour A; Coulon P; Brahimi M; Benhassine M
Arch Inst Pasteur Alger; 1992; 58():283-90. PubMed ID: 1309144
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies.
Lafon M; Ideler J; Wunner WH
Dev Biol Stand; 1984; 57():219-25. PubMed ID: 6084612
[TBL] [Abstract][Full Text] [Related]
14. Novel monoclonal antibodies that bind to wild and fixed rabies virus strains.
Zanluca C; Aires LR; Mueller PP; Santos VV; Carrieri ML; Pinto AR; Zanetti CR
J Virol Methods; 2011 Jul; 175(1):66-73. PubMed ID: 21536074
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of human monoclonal antibodies to G5, a linear neutralization epitope on glycoprotein of rabies virus, by phage display technology.
Zhao XL; Yin J; Chen WQ; Jiang M; Yang G; Yang ZH
Microbiol Immunol; 2008 Feb; 52(2):89-93. PubMed ID: 18380806
[TBL] [Abstract][Full Text] [Related]
16. A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge.
Saxena S; Dahiya SS; Sonwane AA; Patel CL; Saini M; Rai A; Gupta PK
Vaccine; 2008 Dec; 26(51):6592-601. PubMed ID: 18848857
[TBL] [Abstract][Full Text] [Related]
17. [Antigenic variants of the rabies virus. Selection with antiglycoprotein monoclonal antibodies].
Coulon P; Rollin P; Aubert M; Flamand A
Arch Inst Pasteur Tunis; 1982 Mar; 59(1):105-13. PubMed ID: 7181560
[No Abstract] [Full Text] [Related]
18. A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency.
Lin G; Chen S; Zhao H; Liang J; Deng Q; Liang R; Guo X; Chen Z; Chen B; Liu T; Wu Y
Sci Rep; 2017 Aug; 7(1):7288. PubMed ID: 28779162
[TBL] [Abstract][Full Text] [Related]
19. Competitive ELISA using a rabies glycoprotein-transformed cell line to semi-quantify rabies neutralizing-related antibodies in dogs.
Zhang S; Liu Y; Zhang F; Hu R
Vaccine; 2009 Mar; 27(15):2108-13. PubMed ID: 19356613
[TBL] [Abstract][Full Text] [Related]
20. Use of an enzyme immunoassay with protein A for rabies antigen and antibody determination.
Atanasiu P; Perrin P; Delagneau JF
Dev Biol Stand; 1980; 46():207-15. PubMed ID: 6988255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
